August 1, 2024
Though prostate cancer may not receive as much media attention as breast cancer, it is nearly as common, affecting about 1 in 8 men in their lifetime.
In 2024, about 299,010 men will be newly diagnosed with prostate cancer, more than any type of cancer aside from skin cancer, and about 35,250 men will die from prostate cancer—the most deaths from any cancer in men after lung and bronchus cancer.*
Receiving proper health screenings can be lifesaving. Unfortunately, research shows that men are less likely to visit their primary care doctor than women. A 2022 survey by the Cleveland Clinic revealed that more than half of men surveyed said they do not receive regular health screenings, and 77 percent of men did not know their complete family history regarding urological issues.
The American College of Surgeons (ACS) has partnered with the American Urological Association (AUA) to share vital information about the concerning rise in advanced cases of prostate cancer and how men can protect their health and make the most informed decisions about their healthcare. More information is also available at the Prostate Cancer Information Center of the AUA Urology Care Foundation.
*Data from: American Cancer Society. Cancer Facts & Figures 2024, Atlanta: American Cancer Society; 2024.
A recording of a virtual Newswise press conference, held on September 11, 2023, is available to view online. The press conference includes commentary from ACS Governor James Eastham, MD, FACS, chief of urology service at Memorial Sloan Kettering Cancer Center, Kara Watts, MD, an associate professor of Urology at Montefiore Medical Center, and Kevin Koo, MD, MPH, an associate professor of Urology at Mayo Clinic College of Medicine and Science.
Dr. Eastham, Dr. Watts, and Dr. Koo discussed:
The prostate is a walnut-sized gland, located at the base of the bladder, that makes up part of the male reproductive system. The main job of the prostate and seminal vesicles is to make fluid for semen.
Prostate cancer develops when abnormal cells form and grow in the prostate gland. Not all abnormal growths, also called tumors, are cancerous (malignant). Some growths may be non-cancerous (benign).
After years of decline, cases of advanced prostate cancer are on the rise. According to the American Cancer Society’s 2023 annual Cancer Facts & Figures report:
Screening remains the most effective way to protect against advanced disease. When caught early, prostate cancer is highly treatable.
Screening for prostate cancer often starts with a simple blood test known as the prostate-specific antigen (PSA) test, which can help detect abnormalities in the prostate. Your doctor may also perform a prostate exam.
The AUA suggests that most men should receive a baseline PSA test between ages 45 to 50 years. Men with a family history or who are at increased risk of prostate cancer, including Black men, should talk to their doctor about screening earlier.
Learn more about the PSA test and another screening method, a digital rectal exam, with resources from the AUA.
"If you take your car for a tune-up twice a year, you should also make sure you're seeing your doctor and having these important conversations to make sure you too are tuned-up."
Any genetically male patient can develop prostate cancer, but there are additional risk factors that put certain individuals at risk. According to the AUA, factors that increase a man’s risk of developing prostate cancer include:
Treatment for prostate cancer will depend on a variety of factors, and some low-risk prostate cancers may only need to be monitored with an approach called active surveillance, or close monitoring with imaging and tests.
According to the AUA, some factors that may determine treatment options include:
Some common treatment options for prostate cancer include radiation treatment, hormonal therapy, or surgery. Other emerging treatment options include immunotherapy, which harvests the body’s natural immune system to fight the cancer, and focal therapy, which targets smaller tumors using high-intensity focused ultrasound and other techniques.
Read more on treatment options for prostate cancer, including the surgical management of prostate cancer, from the AUA.
"Just because you’re diagnosed with prostate cancer and are referred to a surgeon, that doesn’t mean you’re going to need surgery right away. If you have what we call a low-risk prostate cancer then we would typically do active surveillance, which involves repeat biopsies and additional monitoring with an MRI and PSA testing."
Treatment for prostate cancer has advanced considerably in the past decade, but it can still come with many undesirable side effects that may reduce your quality of life. Having open and honest conversations with your care team about side effects may help you prepare for treatment as well as consider therapies to reduce side effects. Ultimately, decisions should be based on your goals and conversations with your care team. Some questions to consider asking your care team include:
"The first step always starts with bringing any questions or concerns into awareness. If you don't say something about it or the provider doesn't ask, your issues or concerns may not become known. It starts with having a conversation."